Approvals/CIMA-AEMPS/OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA LACER 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA LACER 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Lacer S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: c853aead22889289
Drug Cima Aemps Name: OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA LACER 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 85635
Holder Company Name: Lacer S.A.
Marketing Company Name: Lacer S.A.
Authorization Date: 2020-12-09
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 20 mg/5 mg/12,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Lacer S.A.

OLMESARTAN MEDOXOMILO

20 mg

AMLODIPINO BESILATO

6,93 mg

HIDROCLOROTIAZIDA

12,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 9, 2020

Approval ID

c853aead22889289

Type

Standard